HomeBGACF • OTCMKTS
add
BioNeutra Global Corp
Previous close
$0.0056
Year range
$0.010 - $0.010
Market cap
1.39M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.05M | — |
Operating expense | 1.12M | — |
Net income | -412.24K | — |
Net profit margin | -13.52 | — |
Earnings per share | — | — |
EBITDA | -228.58K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 796.54K | — |
Total assets | 13.57M | — |
Total liabilities | 21.81M | — |
Total equity | -8.23M | — |
Shares outstanding | 46.45M | — |
Price to book | -0.03 | — |
Return on assets | -5.00% | — |
Return on capital | 152.79% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -412.24K | — |
Cash from operations | 33.44K | — |
Cash from investing | -13.26K | — |
Cash from financing | -225.05K | — |
Net change in cash | 441.30K | — |
Free cash flow | -54.07K | — |
About
Founded
1996
Headquarters
Website
Employees
51